IP Library Granted Patent US 10,568,856
Granted Patent B2
US 10,568,856 · App. 15/755,349 · Granted Feb 25, 2020

Composition for improved sleep

Inventors: John Doherty (Windsor, CA); Soring Popa (Windsor, CA); Dore Miller (Windsor, CA); Marc Bellemore (Windsor, CA)
A61K31/198A61K9/00A61K9/209A61K31/4045A61K36/28A61K36/41A61K36/539A61K45/06A61P25/20C07C229/24C07D209/14A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,568,856
App. No.
15/755,349
Granted
Feb 25, 2020
Kind
B2
Abstract

Compositions are disclosed for improved sleep quality and quantity including ingredients for both immediate release and controlled release. The invention provides improved supplemental compositions, and methods for administering same to a user, for enhancing the onset, quality, and duration of sleep in humans and animals. The supplemental composition may contain a combination of ingredients in proportions calculated to relieve stress, promote relaxation, and enhance sleep, including at least the following ingredients: L-Theanine, Skullcap Herb ( Scutellaria lateriflora L.), Rhodiola ( Rhodiola rosea L.), and Chamomile Flower ( Matricaria Recutita ). In addition, the supplemental composition may include the secondary ingredient Melatonin. The selection and amounts of the ingredients of the supplemental composition promote sleep onset, quality, and duration and may be provided for consumption at least one time daily, e.g., prior to sleep. The composition may be in a layered solid dosage form to provide controlled and sustained release of specific ingredients.

Claims (16)

1. A composition for promoting sleep in a human or mammal comprising:

a. about 100 mg L-Theanine per serving;

b. about 62.5 mg Skullcap Herb ( Scutellaria lateriflora L.) per serving;

c. about 100 mg Rhodiola ( Rhodiola rosea L.) per serving;

d. about 5.0 mg Chamomile Flower ( Matricaria Recutita ) per serving; and

e. about 5.0 mg Melatonin per serving.

2. The composition of claim 1 , wherein the composition further comprises a controlled release mechanism.

3. The composition of claim 1 , wherein the composition is provided in a solid orally administrable dosage form.

4. The composition of claim 3 , wherein the Melatonin is incorporated into a controlled release format.

5. A two layer tablet for promoting sleep in a human or mammal comprising

a. a first layer in immediate release dosage form comprising

i. about 100 mg L-Theanine;

ii. about 62.5 mg Skullcap Herb ( Scutellaria lateriflora L.);

iii. about 100 mg Rhodiola ( Rhodiola rosea L.);

iv. about 5.0 mg Chamomile Flower ( Matricaria Recutita ); and

b. a second layer comprising about 5.0 mg melatonin in a slow release form.

Assignments (3)
SECURITY INTEREST Recorded Aug 16, 2022
From: JAMIESON LABORATORIES LTD.
To: BANK OF MONTREAL
Reel/Frame 060824/0035 →
SECURITY INTEREST Recorded Feb 14, 2020
From: JAMIESON LABORATORIES LTD.
To: BANK OF MONTREAL
Reel/Frame 051821/0159 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2019
From: DOHERTY, JOHN; MILLER, DORE; POPA, SORIN; BELLEMORE, MARC
To: JAMIESON LABORATORIES, LTD
Reel/Frame 051316/0546 →
Continuity (2)
Provisional Application 62212627 · Sep 1, 2015
Related Publication 20190240178A1 · Aug 8, 2019